Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 5786182, 2 pages
http://dx.doi.org/10.1155/2016/5786182
Editorial

Sepsis: Diagnostic and Therapeutic Challenges

1Department of Anaesthesiology and Intensive Therapy, Faculty of Medicine, University of Szeged, 6 Semmelweis St., Szeged 6725, Hungary
24th Department of Internal Medicine, Attikon University Hospital, 1 Rimini Str., 12462 Athens, Greece
3Sections of Critical Care Medicine and Infectious Diseases, Medical Microbiology and Pharmacology, University of Manitoba, Winnipeg, MB, Canada
4Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, 20151 Hamburg, Germany

Received 18 September 2016; Accepted 18 September 2016

Copyright © 2016 Zsolt Molnár et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K.-M. Kaukonen, M. Bailey, S. Suzuki, D. Pilcher, and R. Bellomo, “Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000–2012,” Journal of the American Medical Association, vol. 311, no. 13, pp. 1308–1316, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. D. F. Gaieski, J. M. Edwards, M. J. Kallan, and B. G. Carr, “Benchmarking the incidence and mortality of severe sepsis in the united states,” Critical Care Medicine, vol. 41, no. 5, pp. 1167–1174, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. C. M. Torio and R. M. Andrews, “National Inpatient Hospital Costs: The Most Expensive Conditions by Payer, 2011: Statistical Brief #160,” Healthcare Cost and Utilization Project (HCUP) Statistical Briefs, Agency for Health Care Policy and Research, Rockville, Md, USA, 2006–2013
  4. S. Heublein, M. Hartmann, S. Hagel, R. Hutagalung, and F. M. Brunkhorst, “Epidemiology of sepsis in German hospitals derived from administrative databases,” Infection, vol. 17, article S71, 2013. View at Google Scholar
  5. C. Engel, F. M. Brunkhorst, H.-G. Bone et al., “Epidemiology of sepsis in Germany: results from a national prospective multicenter study,” Intensive Care Medicine, vol. 33, no. 4, pp. 606–618, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. I. László, D. Trásy, Z. Molnár, and J. Fazakas, “Sepsis: from pathophysiology to individualized patient care,” Journal of Immunology Research, vol. 2015, Article ID 510436, 13 pages, 2015. View at Publisher · View at Google Scholar
  7. R. C. Bone, C. J. Fisher Jr., T. P. Clemmer, G. J. Slotman, G. A. Metz, and R. A. Balk, “Sepsis syndrome: a valid clinical entity. Methylprednisolone Severe Sepsis Study Group,” Critical Care Medicine, vol. 17, no. 5, pp. 389–393, 1989. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Singer, C. S. Deutschman, C. W. Seymour et al., “The third international consensus definitions for sepsis and septic shock (Sepsis-3),” Journal of the American Medical Association, vol. 315, no. 8, pp. 801–810, 2016. View at Publisher · View at Google Scholar
  9. J.-L. Vincent, “We should abandon randomized controlled trials in the intensive care unit,” Critical Care Medicine, vol. 38, no. 10, pp. S534–S538, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Kumar, D. Roberts, K. E. Wood et al., “Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock,” Critical Care Medicine, vol. 34, no. 6, pp. 1589–1596, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. R. S. Hotchkiss, G. Monneret, and D. Payen, “Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach,” The Lancet Infectious Diseases, vol. 13, no. 3, pp. 260–268, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Monneret and F. Venet, “Sepsis-induced immune alterations monitoring by flow cytometry as a promising tool for individualized therapy,” Cytometry Part B: Clinical Cytometry, vol. 90, no. 4, pp. 376–386, 2016. View at Publisher · View at Google Scholar